Lakefront Biotherapeutics (GLPGF) Tax Rate Growth (1y) (2015 - 2026)
Powered by 
Analysis
Lakefront Biotherapeutics (GLPGF) Tax Rate Growth (1y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.28 Bn | 197.29 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.28 Bn | 178.10 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.26 Bn | 124.41 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.58 Bn | 74.58 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.67 Bn | 56.48 Bn | 1.37 Bn |
| 6 | Moderna | 54.58 Bn | 49.44 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.01 Bn | 30.70 Bn | 992.69 Mn |
| 8 | Biogen | 31.26 Bn | 29.98 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.78 Bn | 29.78 Bn | 1.16 Mn |
| 10 | Lakefront Biotherapeutics | 1.73 Bn | 1.73 Bn | 3.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.00 |
| Mar 31, 2026 | 66.00 |
| Dec 31, 2025 | 617.00 |
| Sep 30, 2025 | -170.00 |
| Jun 30, 2025 | 131.00 |
| Mar 31, 2025 | -364.00 |
| Dec 31, 2024 | 4.00 |
| Sep 30, 2024 | 187.00 |
| Jun 30, 2024 | -9,681.00 |
| Mar 31, 2024 | 410.00 |
| Dec 31, 2023 | -84.00 |
| Sep 30, 2023 | -575.00 |
| Jun 30, 2023 | 9,441.00 |
| Mar 31, 2023 | -1,651.00 |
| Dec 31, 2022 | 4,168.00 |
| Sep 30, 2022 | 211.00 |
| Jun 30, 2022 | 5.00 |
| Mar 31, 2022 | 1,330.00 |
| Dec 31, 2021 | -4,155.00 |
| Sep 30, 2021 | -59.00 |